Published in Cytokine Growth Factor Rev on September 01, 1997
Interferon-lambda: a new addition to an old family. J Interferon Cytokine Res (2010) 2.15
Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription. J Virol (2000) 1.79
Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in mice. Proc Natl Acad Sci U S A (1998) 1.27
Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells. J Immunol (2012) 1.23
IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors. Cancer Cell Int (2011) 1.10
Modulation of gamma interferon receptor 1 by Mycobacterium tuberculosis: a potential immune response evasive mechanism. Infect Immun (2007) 1.07
Engineering DNA nanoparticles as immunomodulatory reagents that activate regulatory T cells. J Immunol (2012) 1.06
IFN consensus sequence binding protein potentiates STAT1-dependent activation of IFNgamma-responsive promoters in macrophages. Proc Natl Acad Sci U S A (2000) 1.00
CANDO and the infinite drug discovery frontier. Drug Discov Today (2014) 0.94
The intracellular domain of interferon-alpha receptor 2c (IFN-alphaR2c) chain is responsible for Stat activation. Proc Natl Acad Sci U S A (1999) 0.92
Regulation of interferon gamma signaling by suppressors of cytokine signaling and regulatory T cells. Front Immunol (2013) 0.90
Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs. Front Immunol (2015) 0.90
Physiological and receptor-selective retinoids modulate interferon gamma signaling by increasing the expression, nuclear localization, and functional activity of interferon regulatory factor-1. J Biol Chem (2005) 0.89
Biologic functions of the IFN-gamma receptors. Allergy (1999) 0.87
Differential induction of Ly6G and Ly6C positive myeloid derived suppressor cells in chronic kidney and liver inflammation and fibrosis. PLoS One (2015) 0.85
Partial IFN-γR2 deficiency is due to protein misfolding and can be rescued by inhibitors of glycosylation. Blood (2013) 0.83
Deregulation of Interferon Signaling in Malignant Cells. Pharmaceuticals (Basel) (2010) 0.81
Interferon gamma-induced apoptosis of head and neck squamous cell carcinoma is connected to indoleamine-2,3-dioxygenase via mitochondrial and ER stress-associated pathways. Cell Div (2016) 0.79
Malignant germ cell tumours of the testis express interferon-gamma, but are resistant to endogenous interferon-gamma. Br J Cancer (2003) 0.79
Elucidating the crosstalk mechanism between IFN-gamma and IL-6 via mathematical modelling. BMC Bioinformatics (2013) 0.78
Improving the spectral analysis of Fluorescence Resonance Energy Transfer in live cells: application to interferon receptors and Janus kinases. Cytokine (2013) 0.78
Phosphorylation of Y372 is critical for Jak2 tyrosine kinase activation. Cell Signal (2011) 0.76
Critical role of the endogenous interferon ligand-receptors in type I and type II interferons response. Immunology (2014) 0.76
MD-2 is involved in the stimulation of matrix metalloproteinase-1 expression by interferon-γ and high glucose in mononuclear cells - a potential role of MD-2 in Toll-like receptor 4-independent signalling. Immunology (2013) 0.76
PEGylation improves the pharmacokinetic properties and ability of interferon gamma to inhibit growth of a human tumor xenograft in athymic mice. J Interferon Cytokine Res (2014) 0.75
Crystal structure of human interferon-γ receptor 2 reveals the structural basis for receptor specificity. Acta Crystallogr D Struct Biol (2016) 0.75
Potential Involvement of Type I Interferon Signaling in Immunotherapy in Seasonal Allergic Rhinitis. J Immunol Res (2016) 0.75
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature (2010) 8.78
Oncogenically active MYD88 mutations in human lymphoma. Nature (2010) 7.34
Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol (1995) 3.76
Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci U S A (2000) 2.83
PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins. J Biol Chem (2001) 2.67
The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity. J Biol Chem (1999) 2.64
The role of adenosine 3':5'-cyclic monophosphate in the regulation of insulin release by isolated rat islets of Langerhans. Biochem J (1971) 2.41
Intracellular serine protease of Bacillus subtilis: sequence homology with extracellular subtilisins. J Bacteriol (1978) 2.17
Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol (2001) 2.07
Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J (1997) 2.03
Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction. J Exp Med (1994) 2.00
Fourteen internal transcribed spacers in the circular ribosomal DNA of Euglena gracilis. J Mol Biol (1990) 2.00
Modifications of vectors pEF-BOS, pcDNA1 and pcDNA3 result in improved convenience and expression. Biotechniques (1996) 1.69
Identification and sequence of an accessory factor required for activation of the human interferon gamma receptor. Cell (1994) 1.67
1H, 13C, and 15N NMR backbone assignments and secondary structure of human interferon-gamma. Biochemistry (1992) 1.66
Biphasic effect of interferon-gamma in murine collagen-induced arthritis. Eur J Immunol (1995) 1.63
A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses. Mol Cell Biol (1997) 1.62
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. Allergy (2009) 1.62
Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis. Eur J Immunol (1995) 1.62
Isolation and characterization of Ni-specific T cell clones from patients with Ni-contact dermatitis. J Immunol (1985) 1.59
Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun (2000) 1.58
Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience). Am J Cardiol (2001) 1.49
The use of rectal temperature to monitor heat stroke. Mo Med (1992) 1.49
Interferon-gamma induces tyrosine phosphorylation of interferon-gamma receptor and regulated association of protein tyrosine kinases, Jak1 and Jak2, with its receptor. J Biol Chem (1994) 1.46
Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study. Diabetes Care (1999) 1.43
Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. J Exp Med (1996) 1.38
Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol Res (1998) 1.36
Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J Immunol (2001) 1.35
Interaction between the components of the interferon gamma receptor complex. J Biol Chem (1995) 1.32
Murine monoclonal antibodies against HLA structures. Immunol Rev (1979) 1.31
IFN-gamma involvement in the severity of gram-negative infections in mice. J Immunol (1993) 1.30
Distribution of interferon-gamma receptor in human tissues. Eur J Immunol (1992) 1.30
Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors. J Exp Med (1997) 1.29
Stability over time of variables measuring heart rate variability in normal subjects. Am J Cardiol (1991) 1.27
Baculovirus stimulates antiviral effects in mammalian cells. J Virol (1999) 1.26
The Jak kinases differentially associate with the alpha and beta (accessory factor) chains of the interferon gamma receptor to form a functional receptor unit capable of activating STAT transcription factors. J Biol Chem (1995) 1.24
Purification and properties of serine protease from Halobacterium halobium. J Bacteriol (1983) 1.24
Intracellular serine protease from Bacillus subtilis. Structural comparison with extracellular serine proteases-subtilisins. Biochem Biophys Res Commun (1977) 1.23
Synthesis and NMR spectral study of some t(3)-aryl-r(2),c(4)-bisethoxycarbonyl-t(5)-hydroxy-c(5)-methylcyclohexanones. Magn Reson Chem (2005) 1.23
Regulation of apoptosis by type III interferons. Cell Prolif (2008) 1.19
Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation. J Immunol (2001) 1.18
A single amino acid determines the immunostimulatory activity of interleukin 10. J Exp Med (2000) 1.16
A simple, rapid and large capacity ELISA for biologically active native and recombinant human IFN gamma. J Biol Regul Homeost Agents (1988) 1.14
Long-term outcome following coronary stent embolization or misdeployment. Am J Cardiol (2001) 1.14
Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury. Am J Pathol (1996) 1.13
The effects of a nonimmunogenic form of murine soluble interferon-gamma receptor on the development of autoimmune diabetes in the NOD mouse. Endocrinology (1996) 1.12
Hsl7p, the yeast homologue of human JBP1, is a protein methyltransferase. Biochem Biophys Res Commun (2000) 1.11
Sn-glycerol-3-phosphate dehydrogenase gene expression during mouse adipocyte development in vivo. Dev Biol (1982) 1.11
Optic nerve colobomas of autosomal-dominant heredity. Arch Ophthalmol (1976) 1.11
Other kinases can substitute for Jak2 in signal transduction by interferon-gamma. J Biol Chem (1996) 1.09
Environmental signals influencing expression of the IFN-gamma receptor on human T cells control whether IFN-gamma promotes proliferation or apoptosis. J Immunol (1994) 1.06
Stoichiometry of interaction between interferon gamma and its receptor. Eur J Biochem (1992) 1.05
Molecular cloning and structural analysis of the human gene encoding cellular retinaldehyde-binding protein. J Biol Chem (1994) 1.03
Role of interferon-gamma in mediating the antitumor efficacy of interleukin-12. J Immunother Emphasis Tumor Immunol (1995) 1.01
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. J Immunol (1999) 1.01
The effects of a monoclonal antibody to interferon-gamma on experimental autoimmune thyroiditis (EAT): prevention of disease and decrease of EAT-specific T cells. Eur J Immunol (1993) 1.00
Mouse soluble IFN gamma receptor as IFN gamma inhibitor. Distribution, antigenicity, and activity after injection in mice. J Immunol (1993) 1.00
The role of mRNA levels and cellular localization in controlling sn-glycerol-3-phosphate dehydrogenase expression in tissues of the mouse. J Biol Chem (1981) 1.00
The in vivo antiviral activity of interleukin-12 is mediated by gamma interferon. J Virol (1995) 0.99
Observation of an unexpected third receptor molecule in the crystal structure of human interferon-gamma receptor complex. Structure (2000) 0.99
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes. J Immunol (2000) 0.98
hTid-1, a human DnaJ protein, modulates the interferon signaling pathway. J Biol Chem (2001) 0.97
Induction of the ubiquitin-proteasome pathway during the keratocyte transition to the repair fibroblast phenotype. Invest Ophthalmol Vis Sci (2001) 0.96
The complete primary structure of mouse alpha 2(IV) collagen. Alignment with mouse alpha 1(IV) collagen. J Biol Chem (1989) 0.96
Molecular characterization of the murine interferon gamma receptor cDNA. J Biol Chem (1989) 0.96
On the appearance of Bacillus subtilis intracellular serine protease in the cell membrane and culture medium. Comparison of the enzyme and other Bacillus subtilis serine proteases. Arch Microbiol (1978) 0.95
Photo-inhibition of cell division and growth in euglenoid flagellates. J Cell Physiol (1968) 0.95
CD4+ and CD8+ lymphocytes of patients with AIDS synthesize increased amounts of interferon-gamma. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.94
Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha- and beta-chains of its receptor. J Immunol (1996) 0.94
Properties of partially purified malate synthase for Euglena gracilis. J Protozool (1970) 0.93
Separation of human cells bearing HLA-DR antigens using a monoclonal antibody rosetting method. Tissue Antigens (1979) 0.93
Identity between human interferon-gamma and "macrophage-activating factor" produced by human T lymphocytes. Eur J Immunol (1986) 0.93
Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice. Eur J Immunol (2000) 0.93
Photosynthetic activity during the division cycle in synchronized Euglena gracilis. Plant Physiol (1966) 0.93
The intracellular domain of interferon-alpha receptor 2c (IFN-alphaR2c) chain is responsible for Stat activation. Proc Natl Acad Sci U S A (1999) 0.92
Quantitative analysis of cell surface HLA structures by means of monoclonal antibodies. Hum Immunol (1980) 0.91
Purification and biochemical characterization of a soluble human interferon gamma receptor expressed in Escherichia coli. J Biol Chem (1990) 0.91
Identification of a yeast artificial chromosome clone encoding an accessory factor for the human interferon gamma receptor: evidence for multiple accessory factors. Proc Natl Acad Sci U S A (1993) 0.91
New vectors for manipulation and selection of functional yeast artificial chromosomes (YACs) containing human DNA inserts. Gene (1995) 0.91
Unbalanced respiratory growth of euglena. J Gen Microbiol (1968) 0.90
Does cardioplegia type affect outcome and survival in patients with advanced left ventricular dysfunction? Results from the CABG Patch Trial. Circulation (2000) 0.89
The synthesis of cytoplasmic DNA in synchronized Euglena. J Cell Biol (1966) 0.89
CKbeta8, a novel CC chemokine that predominantly acts on monocytes. FEBS Lett (1997) 0.89
Effectiveness of bi-atrial pacing for reducing atrial fibrillation after coronary artery bypass graft surgery. J Interv Card Electrophysiol (2001) 0.88
Ultraviolet bleaching of synchronized Euglena. Photochem Photobiol (1965) 0.88
Analysis of soluble human and mouse interferon-gamma receptors expressed in eukaryotic cells. Eur J Biochem (1992) 0.88
Role of serum amyloid A as an intermediate in the IL-1 and PMA-stimulated signaling pathways regulating expression of rabbit fibroblast collagenase. Exp Cell Res (1997) 0.88
Studies on the respiratory physiology of Euglena gracilis cultured on acetate or glucose. J Protozool (1967) 0.88
In vitro studies in nickel allergy: diagnostic value of a dual parameter analysis. J Invest Dermatol (1987) 0.87